BennettW, PlampCE, GilbertDN, ParkerRA, PorterGA. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure.J Infect Dis1979; 140: 57680.
4.
Ter BraakEW, De VriesPJ, BouterKPOnce-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.Am J Med1990; 89: 5866.
5.
GiulianoRA, VerpootenGA, VerbistL, WedeenRP, De BroeME. In vivo uptake kinetics of aminoglycosides in the kidney cortex in rats.J Pharmacol Exp Ther1986; 236: 4705.
6.
GiulianoRA, VerpootenGA, De BroeME. The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats.Am J Kidney Dis1986; 8: 297303.
7.
MooreRD, LietmanPS, SmithCR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.J Infect Dis1987; 155: 939.
8.
NordstromL, CronsbergS, RingbergH, TjernstromO, WalderM.Prospective, comparative, randomized clinical study of aminoglycosides given once a day versus three times a day in severe infections. In: IschigamiJ, ed. Recent advances in chemotherapy.Tokyo: University of Tokyo Press, 1985; 26534.
9.
MallerR, IsakssonB, NilssonL, SorenL.A study of amikacin given once versus twice daily in serious infections.J Antimicrob Chemother1988; 22: 759.
10.
StrumAW. Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage.J Infect Dis1989; 159: 9317.
11.
FanST, LauWY, Teoh-ChanCH, LauKF, MauracherEH,. Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis.J Antimicrob Chemother1988; 22: 6774.
